Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial

This study is ongoing, but not recruiting participants.

Study NCT00310388 Information provided by GlaxoSmithKline

First Received: March 30, 2006 Last Updated: September 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2014
Estimated Primary Completion Date:	July 2014 (Final data collection date for primary outcome measure)